Wanwarang Wongcharoen

Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

  • OrcidID

Articles by Wanwarang Wongcharoen

Expert Opinion on the Use of Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes and Established or High-risk Atherosclerotic Cardiovascular Disease in Thailand

Wanwarang Wongcharoen, Rungroj Krittayaphong, Wacin Buddhari, et al

Published:

Citation: Journal of Asian Pacific Society of Cardiology 2025;4:e14.